{
    "nctId": "NCT02408406",
    "briefTitle": "PatientCareAnywhere Internet-Based Software in Improving Communication and Education in Patients With Cancer and Their Healthcare Providers",
    "officialTitle": "PatientCareAnywhere: Patient Support and Empowerment Across the Care Continuum",
    "overallStatus": "COMPLETED",
    "conditions": "Bladder Carcinoma, Breast Carcinoma, Colorectal Carcinoma, Lung Carcinoma, Malignant Female Reproductive System Neoplasm, Malignant Neoplasm",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 140,
    "primaryOutcomeMeasure": "Functional Assessment of Cancer Therapy-General (FACT-G) scores",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* PHASE I AIM 1 (STAKEHOLDER INPUT)\n* PHASE I AIM 1: Malignant diagnosis in any cancer type at any stage\n* PHASE I AIM 1: Receiving any type of cancer treatment\n* PHASE I AIM 1: Life expectancy of at least six months\n* PHASE I AIM 1: Current outpatient status\n* PHASE I AIM 1: Fluent in English\n* PHASE I AIM 1: Internet access at home\n* PHASE I AIM 3.1 (EVALUATION STUDY)\n* PHASE I AIM 3.1: Malignant diagnosis in any cancer type at any stage\n* PHASE I AIM 3.1: Receiving any type of cancer treatment\n* PHASE I AIM 3.1: Life expectancy of at least six months\n* PHASE I AIM 3.1: Current outpatient status\n* PHASE I AIM 3.1: Fluent in English\n* PHASE I AIM 3.1: Internet access at home\n* PHASE I AIM 3.2 (PILOT STUDY)\n* PHASE I AIM 3.2: Malignant diagnosis in breast, gynecologic (GYN), genitourinary (GU) cancer at any stage\n* PHASE I AIM 3.2: Receiving surgery and/or chemotherapy treatment\n* PHASE I AIM 3.2: Life expectancy of at least six months\n* PHASE I AIM 3.2: Current outpatient status (participation will be suspended during hospitalization)\n* PHASE I AIM 3.2: Fluent in English\n* PHASE I AIM 3.2: Internet access at home\n* PHASE II AIM 2 (RANDOMIZED CONTROLLED TRIAL)\n* PHASE II AIM 2: Malignant diagnosis of breast, lung, or colorectal cancer at any stage\n* PHASE II AIM 2: Receiving any type of cancer treatment\n* PHASE II AIM 2: Life expectancy of at least six months\n* PHASE II AIM 2: Current medical oncology outpatient status (participation will be suspended during hospitalization)\n* PHASE II AIM 2: Fluent in English\n* PHASE II AIM 2: Internet access at home\n\nExclusion Criteria:\n\n* PHASE I AIM 1 (STAKEHOLDER INPUT) EXCLUSION\n* PHASE I AIM 1: Clinical evidence of cognitive or psychological impairment\n* PHASE I AIM 1: Prisoners and pregnant women\n* PHASE I AIM 3.1 (EVALUATION STUDY) EXCLUSION\n* PHASE I AIM 3.1: Clinical evidence of cognitive or psychological impairment\n* PHASE I AIM 3.1: Prisoners and pregnant women\n* PHASE I AIM 3.2 (PILOT STUDY) EXCLUSION\n* PHASE I AIM 3.2: Clinical evidence of cognitive or psychological impairment\n* PHASE I AIM 3.2: Prisoners and pregnant women\n* PHASE I AIM 3.2: Currently participating in other psychosocial studies\n* PHASE II AIM 2 (RANDOMIZED CONTROLLED TRIAL) EXCLUSION\n* PHASE II AIM 2: Clinical evidence of cognitive or psychological impairment\n* PHASE II AIM 2: Prisoners and pregnant women\n* PHASE II AIM 2: Currently participating in other psychosocial studies",
    "sex": "ALL",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}